z-logo
open-access-imgOpen Access
Economic Burden of Disease Progression Among Transplant Eligible Multiple Myeloma Patients Who Have Received at Least One Line of Therapy in the US
Author(s) -
Rafaël Fonseca,
May Hagiwara,
Sumeet Panjabi,
Emre Yücel,
Jacqueline Buchanan,
Thomas E. Delea
Publication year - 2019
Publication title -
blood
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.515
H-Index - 465
eISSN - 1528-0020
pISSN - 0006-4971
DOI - 10.1182/blood-2019-123743
Subject(s) - medicine , multiple myeloma , disease , disease burden , surgery

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom